Viewing Study NCT02008357


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-02-01 @ 12:05 PM
Study NCT ID: NCT02008357
Status: COMPLETED
Last Update Posted: 2023-12-28
First Post: 2013-12-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cognition Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cognition View
None Prevention View